Assistant Professor, International Health
Suffolk University, JD
Boston University, PhD
Boston University School of Public Health, MPH
Texas A&M University, MS
- Office: Crosstown Center, CT395
- Phone: 617-414-1152
- Email: email@example.com
Warren Kaplan, PhD, JD, MPH, MS, has over 30 years’ experience as a field biologist/analytical chemist, an intellectual property attorney, a pharmaceutical policy analyst, and a project leader. Currently, Dr. Kaplan is Assistant Professor of International Health at Boston University School of Public Health, where he teaches courses in pharmaceutical policy, intellectual property policy, and access to medicines and antimicrobial resistance. From 1977 to 1989, Dr. Kaplan worked at Harvard University, traveling to the Caribbean, Ecuador, and Brazil to study global budgets of greenhouse gases, including methane and nitrous oxide. He was part of the first group to measure the global distribution and production of these important climate modifiers. He was Assistant General Counsel at Biogen, where he managed a multimillion portfolio of intellectual property related to small molecules and biologics. He consults extensively with the World Health Organization, UNITAID, UNICEF (South Africa, Mozambique), the World Bank, and the Clinton Foundation (Rwanda, Kenya) on a variety of projects involving access to medicines. Dr. Kaplan has worked and lived in Geneva as Technical Officer on the “Priority Medicines for Europe and the World” Project. He is involved in a similar project on medical devices. Dr. Kaplan’s current research interests focus on pharmaceutical policies relating to generic medicines and biologics as well as use of social networking and mobile phones as health care interventions. He holds a PhD in Biology from Boston University, a JD from Suffolk University (cum laude), an MPH in International Health from Boston University, and an MS from Texas A&M University .
Dr. Kaplan is also a member of the World Health Organization Collaborating Center on Pharmaceutical Policy (WHOCCPP) which provides research and programs for the improvement of access to essential drugs in developing countries and the development of policies that promote greater affordability and the appropriate usage of these medicines.
Policies to promote use of generic medicines in low and middle income countries: A review of published literature, 2000-2010
Health Policy. 2012 Jul; 106(3):211-224.
Policies to promote use of generic medicines in low and middle income countries: A review of published literature, 2000–2010
Health Policy. 2012 Jun; 1-14.
Allocating scarce financial resources for HIV treatment: benchmarking prices of antiretroviral medicines in Latin America
Health Policy & Planning. 2012 Feb;.
Local production of medical technologies and its effect on access in low and middle income countries: a systematic review of the literature
Southern Med Review. 2011 Dec; 4(2):4-14.
Allocating Scarce Financial Resources for HIV Treatment: Benchmarking Prices of Antiretroviral Medicines in Latin America
Health Policy and Planning. 2011 Dec; 1-11.
Temporal Trends in Generic and Brand Prices of Antiretroviral Medicines Procured with Donor Funds in Developing Countries
Journal of Generic Medicines. 2010 Apr; 7(2):159-175.
PLoS Med. 2010 Jan; 7(1):e1000208.
Global Strategies to Reduce the Price of Antiretroviral Medicines: Evidence from Transactional Databases
Bull World Health Organ. 2009 Aug; 87(7):520-8.
Operationalising Patent Pools for ARVs. Kaplan W. A.. Bellagio, Italy: Center for International Health and Development, Boston University; 2007.
The Power of Pills: Social Ethical and Legal Issues in Drug Development, Marketing and Pricing. Schuklenk U., Illingworth P., Cohen J. C.. London, UK: 2007.
United Kingdom Department for International Development. London: United Kingdom Department for International Development; 2007.
BMJ. 2006 Jul; 333(7557):44-5.
Can the Ubiquitous Power of Mobile Phones Be Used to Improve Health Outcomes in Developing Countries?
Global Health. 2006 May; 2:9.
Using IP Agreements to Promote the Objectives of Public Private Partnerships in Developing Affordable Products for Developing Countries
Commission in Intellectual Property, Innovation and Health. Geneva, Switzerland: World Health Organization; 2005.
Health, Nutrition and Population Discussion Paper. Washington, D. C.: World Bank; 2005.
Geneva, Switzerland: World Health Organization; 2004.
Health Policy Plan. 2003 Aug; 18(3):237-48.
Journal of Biolaw and Business. 2001 Jan; 4(Supplement):34-48.
Patentability of Biotechnology Inventions Under the Patent and Trademark Office (PTO) Utility Guidelines: Still Uncertain after all these Years
Journal of Biolaw and Business. 2001 Jan; 4(Special Supplement):34-48.
J. Geophys. Res.-Atmospheres. 1988 Jan; 93(2):1389-1395.
J. Geophys. Res.-Atmospheres. 1988 Jan; 93(2):1600-1604.
J. Geophys. Res.-Atmospheres. 1988 Jan; 93(2):1377-1387.
J. Geophys. Res.-Atmospheres. 1986 Jan; 91(11):1791-1802.
Microbios.. 1985 Jan; 42(169):133-144.
Limnol. Oceanogr.. 1984 Jan; 29(1):84-98.
London: Academic Press, Inc.; 1983.
Geophys. Res. Lett.. 1983 Jan; 10(12):1156-1159.
Deep-Sea Res. Part A-Oceanographic Research Papers. 1983 Jan; 30(6):575-590.
Appl Environ Microbiol. 1980 Sep; 40(3):526-32.
Limonl. & Oceanogr.. 1979 Jan; 24(4):726-734.
Nature. 1978 Oct; 275(5681):602-606.
Nitrous Oxide in Fresh Water Systems: An Estimate for the Yield of Atmospheric N2O Associated with Disposal of Human Waste
Pure and Applied Geophysics. 1978 Jan; 116(2):423-438.
Limnol. Oceanogr.. 1978 Jan; 23(6):1168-1182.
Denitrification in Salt Marsh Sediments: Evidence for Seasonal Temperature Selection among Populations of Denitrifiers
Microbial Ecology. 1977 Sep; 3(3):193-204.